ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

ACR Convergence 2021

November 5-9, 2021. All Virtual.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
  • Abstract Number: 0272
    RA Disease Activity Is an Independent Predictor of Left Ventricular Mass Changes in an RA Cohort Without Cardiovascular Disease
  • Abstract Number: 0616
    Race and Socioeconomic Status and COVID-19 Outcomes in Patients with Rheumatic Diseases: Findings from a Tertiary Care Center in the Deep South
  • Abstract Number: 0771
    Race, Ethnicity and Patient-Reported Outcomes in Childhood-Onset Systemic Lupus Erythematosus
  • Abstract Number: 0619
    Racial and Ethnic Disparities in Pregnancy Outcomes Among Women with Rheumatic Diseases: A Systematic Literature Review and Quantitative Analysis
  • Abstract Number: 0329
    Racial and Ethnic Disparities in Risk of End-Organ Disease Following SLE Diagnosis in a Multi-Ethnic Cohort
  • Abstract Number: 1023
    Racial and Ethnic Distribution of Rheumatic Diseases in Health Systems of the National Patient-Centered Clinical Research Network
  • Abstract Number: 1264
    Racial Differences in Chronic Glucocorticoid Use in Patients with SLE: A Cross Sectional Study
  • Abstract Number: 0492
    Racial Differences in Glucocorticoid Use Among Medicaid Beneficiaries with Incident Systemic Lupus Erythematosus
  • Abstract Number: 0601
    Racial Differences in Medication Beliefs Among SLE Patients
  • Abstract Number: 1780
    Racial Disparities in Comorbidities of Patients with Psoriatic Arthritis
  • Abstract Number: 0956
    Racial Disparities in Renal Outcomes over Time Among Hospitalized Children with SLE and Effects of Hospital Minority Composition
  • Abstract Number: 0596
    Racial Disparities in US Adults with Systemic Lupus Erythematosus: Prevalence, Quality of Life, Comorbidities and Healthcare Costs
  • Abstract Number: 1034
    Racial/ethnic Differences in Lupus Pregnancy Outcomes over 1 Decade: A US National Study
  • Abstract Number: 0495
    Racial/Ethnic Differences in Multimorbidity Between Patients with Systemic Lupus Erythematosus and Comparators in a Large Nationwide US Study
  • Abstract Number: 0613
    Racial/Ethnic Disparities in Prescription Medications in a Large Urban Medical Center
  • Abstract Number: 0907
    Radiographic Sacroiliitis Progression up to Six Years of Follow-Up in Patients with Non-Radiographic Axial Apondyloarthritis
  • Abstract Number: 0342
    RAIL Distinguishes Responder and Non-Responder in Pediatric Lupus Nephritis
  • Abstract Number: 1815
    Randomised, Double-blind, Placebo-controlled Study of Iguratimod in the Treatment of Active Spondyloarthritis
  • Abstract Number: 0548
    Rapamycin Blocks the Profibrotic Effects of Fli1 Downregulation in Scleroderma Myeloid Cells
  • Abstract Number: 0199
    Rapid Improvement in Cystoid Macular Edema with High Dose Intravenous Methylprednisolone in Non-Infectious Uveitis of Different Immune Mediated Inflammatory Diseases
  • Abstract Number: 0337
    Rarity of Pneumocystis Jirovecii Pneumonia in Patients with Systemic Lupus Erythematosus Using a Real-world, Electronic Health Record
  • Abstract Number: 0113
    Reactogenicity of the SARS-CoV-2 Vaccines Associates with Immunogenicity in Patients with Autoimmune and Inflammatory Disease
  • Abstract Number: 1243
    Real World Validation of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis: Analysis from the RISE Registry
  • Abstract Number: 1884
    Real-life Data for the Use of Anti-TNF Treatment in DADA2
  • Abstract Number: 1818
    Real-World Efficacy of TNF Inhibitors for Treatment of Psoriatic Arthritis by Disease Domains: 6-Month Findings from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
  • Abstract Number: 0129
    Real-World Flare Rates and Progression by Treatment Settings Among the Commercially-Insured Systemic Lupus Erythematosus Population in the U.S
  • Abstract Number: 0586
    Recommended Fiber Intake, but Not Overall Dietary Quality, Is Associated with Reduced Risk of Rheumatoid Arthritis – Results from a Nested Case-control Study
  • Abstract Number: 0788
    Red Cell Distribution Width Is Associated with Baseline 25-hydroxyvitamin D Level Before Methotrexate Therapy in Rheumatoid Arthritis
  • Abstract Number: 1826
    Reduced Burden on Paid and Household Work Productivity with Stringent Thresholds of Disease Control: Further Results from Long-Term Certolizumab Pegol Treatment in Patients with Psoriatic Arthritis
  • Abstract Number: 0231
    Reducing the Number of Outpatient Clinic Visits by Using the Routine Assessment of Patient Index Data 3 as a Screening Tool
  • Abstract Number: 1283
    Reduction in Glucocorticoid Use in Patients with Systemic Lupus Erythematosus Treated with Belimumab: A Large Pooled Analysis of 5 Placebo-Controlled Studies
  • Abstract Number: 1737
    Reduction in Urinary CD163 Is Associated with Treatment Response in the Belimumab Lupus Nephritis Trial
  • Abstract Number: 1427
    Reduction of Cardiovascular Disease and Mortality versus Risk of New Onset Diabetes with Statin Use in Patients with Rheumatoid Arthritis
  • Abstract Number: 1790
    Regional Differences in Clinical Characteristics and Treatment of Psoriatic Arthritis with Axial Involvement: Results from the Cross Sectional International ASAS PerSpA Study
  • Abstract Number: 0850
    Regression Methods for Modeling Western Ontario and McMaster Universities Arthritis Index (WOMAC) Pain Scores for Early Stage Knee Osteoarthritis
  • Abstract Number: 1584
    Relation of Depressive Symptoms to Alterations in Conditioned Pain Modulation in Knee Osteoarthritis: The Multicenter Osteoarthritis Study (MOST)
  • Abstract Number: 1588
    Relation of Foot and Ankle Pain to Worsening Knee Pain: The MOST Study
  • Abstract Number: 0220
    Relation of Knee Extensor Power to Worsening Cartilage Damage in the Knee: The MOST Study
  • Abstract Number: 0980
    Relationship Between Paraoxonase-1 Genotype, Activity, and Malignancies in Patients with RA Receiving Tofacitinib
  • Abstract Number: 1660
    Relationship Between Risk of New Onset Diabetes Mellitus and Exposure to Individual Antirheumatic Drugs in Patients with Rheumatoid Arthritis: A Nationwide Population Study
  • Abstract Number: 1822
    Relationships Between Dermatologic Symptoms and Health-related Quality of Life in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies
  • Abstract Number: 1807
    Relationships Between Fatigue and Hemoglobin/C-Reactive Protein Levels and Associations Between Fatigue and Clinical Response in Patients with Active Psoriatic Arthritis: Results from Two Randomized Controlled Trials of Guselkumab (TREMFYA®)
  • Abstract Number: 0799
    Relationships of Rheumatology Care and Patient Experiences to Rheumatoid Arthritis Remission
  • Abstract Number: 0010
    Relaxed Peripheral Tolerance Drives Broad de Novo Autoreactivity in Severe COVID-19
  • Abstract Number: 1365
    Release of High-Mobility Group Box-1 After an Raynaud’s Attack Potentially Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production in Systemic Sclerosis
  • Abstract Number: 0167
    Reliability of a Novel Pediatric Joint-Specific Scoring System for the Elbow, Wrist and Finger Joints
  • Abstract Number: 0792
    Remission Rates of Patients with Rheumatoid Arthritis in a Tertiary Care
  • Abstract Number: 0462
    Remotely Delivered Cognitive Behavioural and Personalised Exercise Interventions Reduce Fatigue Severity and Impact in Inflammatory Rheumatic Diseases: Results from a Multi-centre Randomised Controlled Parallel Group Trial
  • Abstract Number: 1137
    REMS Technology for the Assessment of Bone Health in a Male Population
  • Abstract Number: 0875
    Renal Function, Adherence and Low Hydroxychloroquine Dosing Predict HCQ Blood Levels and Lupus Disease Activity
  • Abstract Number: 0304
    Renal Involvement in Sjőgren’s Syndrome: Predictors and Impact on Patient Outcome
  • Abstract Number: 0769
    Renal Outcomes in 1528 Childhood-onset Systemic Lupus Erythematosus Patients: A Brazilian Multicenter Study
  • Abstract Number: 1628
    Reproductive Health Knowledge Gaps, Needs, and Barriers Identified by Pediatric Rheumatology Providers
  • Abstract Number: 1158
    Resistance of Patients with Rheumatoid Arthritis to Changing Therapy: A 15-year Follow-up
  • Abstract Number: 0914
    Response to Certolizumab Pegol in Patients with Non-Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Cut-Offs: Post-Hoc Analysis from a Phase 3 Multicenter Study
  • Abstract Number: 1615
    Responsiveness of Quality of Life and Function Assessment to Changes in Topical Eye Medications in Children with Uveitis
  • Abstract Number: 0405
    Retrospective Study on the Prognostic Value of Cardiac Magnetic Resonance Imaging Abnormalities in Systemic Sclerosis
  • Abstract Number: 0554
    Reverse Signaling Through PD-L1 Plays a Central Role in Extracellular Matrix Protein Secretion from Cutaneous Myofibroblasts in Systemic Sclerosis
  • Abstract Number: 1454
    RHAPSODY: Rilonacept, an IL-1α and IL-1β Trap, Resolves Pericarditis Episodes and Reduces Risk of Recurrence in a Phase 3 Trial of Patients with Recurrent Pericarditis
  • Abstract Number: 0115
    Rheumatic Disease Management by Resilient Rheumatology Providers in COVID-19 Pandemic: A National Veterans Affairs Follow-up Survey Assessing Provider Practice and Views Since June 2020
  • Abstract Number: 1167
    Rheumatoid Arthritis Patients’ Treatment Goals Relate to Disease Activity and Rheumatology Experiences
  • Abstract Number: 0803
    Rheumatoid Arthritis Practice Performance (RAPP) Project at 6 Years: Population Medicine (POPMED) Principles and Treat to Target (T2T) Care Yield Dramatic Improvements in Both Outcomes and Access for RA Patients and Productivity for Rheumatologists
  • Abstract Number: 0581
    Rheumatoid Arthritis Treatment Patterns in Massachusetts: Informative Findings from Insurance Claims Data
  • Abstract Number: 0015
    Rheumatoid Factor Recognizes Specific Domains of IgG Heavy Chain Complexed with HLA Class II Molecules
  • Abstract Number: 0253
    Rheumatoid Factor Status as a Predictor of Disease Activity and Disability:An Analysis of the New CARRA Registry Polyarticular Juvenile Idiopathic Arthritis Cohort
  • Abstract Number: 0438
    Rheumatological Immune-Related Adverse Events of Immune Checkpoint Inhibitors Based on the FDA Adverse Event Reporting System
  • Abstract Number: 0740
    Rheumatologists’ and Patients’ Mental Models for Treatment of RA Explain Low Rates of TTT
  • Abstract Number: 0612
    Rheumatology Care for the Underserved in Central Texas
  • Abstract Number: 1190
    Rheumatology Continuing Professional Development for Primary Care Providers: A Systematic Review
  • Abstract Number: 0145
    Rheumatology Provider Perspectives on Using Patient-Reported Outcomes in Clinical Care
  • Abstract Number: 0484
    RheumMadness: Creating an Online Community of Inquiry
  • Abstract Number: 1673
    Riding Multiple Waves of Uncertainty: Real World Canadian RA Patient Outcomes over 1 Year of COVID-19 Restrictions
  • Abstract Number: 0095
    Risk Factors for “Long Haul” COVID-19 in Rheumatology Outpatients in New York City
  • Abstract Number: 1525
    Risk Factors for Anti-infliximab Antibody Formation: Results from a Randomized Controlled Trial
  • Abstract Number: 0284
    Risk Factors for Dementia in Patients with Incident Rheumatoid Arthritis: A Population-based Cohort Study
  • Abstract Number: 0989
    Risk Factors for Hydroxychloroquine Retinopathy and Its Subtypes – Prospective Adjudication Analysis of 4,899 Incident Users
  • Abstract Number: 0958
    Risk Factors for Major Adverse Cardiovascular Events in Patients Aged ≥ 50 Years with RA and ≥ 1 Additional Cardiovascular Risk Factor: Results from a Phase 3b/4 Randomized Safety Study of Tofacitinib vs TNF Inhibitors
  • Abstract Number: 1291
    Risk of Bleeding-related Complications After Kidney Biopsy in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 0285
    Risk of Cardiovascular Disease in Newly Diagnosed Rheumatoid Arthritis: A Current Risk Assessment
  • Abstract Number: 1939
    Risk of Cardiovascular Outcomes in Patients Treated with Tofacitinib: First Results from the Safety of TofAcitinib in Routine Care Patients with Rheumatoid Arthritis (STAR-RA) Study
  • Abstract Number: 1915
    Risk of Cardiovascular Outcomes with Low-Dose Glucocorticoids in Patients with Rheumatoid Arthritis
  • Abstract Number: 1925
    Risk of Heart Failure in Patients with Inflammatory Disease: A Population-Based Study
  • Abstract Number: 0204
    Risk of Hepatitis B Virus Reactivation in Patients with Immune-Mediated Inflammatory Diseases Receiving Biologics: Focus on the Timing of Biologics After Prophylactic Anti-viral Agents
  • Abstract Number: 0111
    Risk of Hospitalization, Admission to Intensive Care and Mortality Due to COVID-19 in Patients with Rheumatic Diseases: A Population-based Matched Cohort Study
  • Abstract Number: 1833
    Risk of Major Adverse Cardiovascular Events (MACE) with Biologic and Targeted Synthetic Antirheumatic Agents in Psoriatic Arthritis: A Systematic Review and Network Meta-analysis
  • Abstract Number: 1898
    Risk of Major Adverse Cardiovascular Events in a Large Cohort of Patients with Acute Calcium Pyrophosphate Crystal Arthritis
  • Abstract Number: 1675
    Risk of Malignancy in Patients Treated with Tofacitinib: Results from the Safety of TofAcitinib in Routine Care Patients with Rheumatoid Arthritis (STAR-RA) Study
  • Abstract Number: 1046
    Risk of Ocular Comorbidities and Blindness Among Patients with Behçet’s Disease: A Nationwide Population-based Cohort Study in Korea
  • Abstract Number: 1136
    Risk of Osteoporosis in Patients with Systemic Sclerosis: A Cross-Sectional Analysis of Two European Prospective Cohorts
  • Abstract Number: 1658
    Risk of Other Autoimmune Conditions Among Relatives of Patients with Rheumatoid Arthritis
  • Abstract Number: 1722
    Risk of Pre-eclampsia and Impact of Disease Activity and Anti-rheumatic Treatment in Women with Rheumatoid Arthritis, Axial Spondylarthritis, and Psoriatic Arthritis – A Collaborative Matched Cohort Study from Sweden and Denmark
  • Abstract Number: 1359
    Risk of Respiratory Tract Infections with Biologic and Targeted Synthetic Antirheumatic Agents in Psoriatic Arthritis: A Systematic Review and Network Meta-analysis
  • Abstract Number: 1713
    Risk of Serious Infections in Offspring Exposed in Utero to Ustekinumab or Vedolizumab
  • Abstract Number: 0505
    Risk of Venous and Arterial Thromboembolism in Patients with Giant Cell Arteritis And/or Polymyalgia Rheumatica: A Veterans Health Administration Population-Based Study in the United States
  • Abstract Number: 0988
    Risk Prediction Models for Incident Systemic Lupus Erythematosus Using Lifestyle/Environmental Risk Factors and a Genetic Risk Score
  • Abstract Number: 1391
    Rituximab Is Superior to Placebo in Polymyalgia Rheumatica Patients: A Double Blind Randomized Controlled Proof of Principle Trial
  • Abstract Number: 0987
    Rituximab Prevents the Progression of B-cell Driven Inflammatory Infiltrate in the Minor Salivary Glands of Primary Sjogren’s Syndrome by Downregulating Immunological Pathways Key in Ectopic Germinal Centre Organization: Results from the TRACTISS Trial
  • Abstract Number: 0964
    Rituximab Treatment Dramatically Reduces Neutralizing Humoral Response to mRNA SARS-COV-2 Vaccines in Patients with Autoimmune Diseases
  • Abstract Number: L21
    Rituximab versus Conventional Therapeutic Strategy for Remission Induction in Eosinophilic Granulomatosis with Polyangiitis: A Double-blind, Randomized, Controlled Trial
  • Abstract Number: 0395
    RNA Polymerase III Autoantibody Levels and Risk of Systemic Sclerosis in Patients with Raynaud Phenomenon
  • Abstract Number: 0323
    Ro Positivity Is an Under‐Recognised Poor Prognostic Marker in Systemic Lupus Erythematosus Patients
  • Abstract Number: 1507
    Role of CD4+ T Cells in the Pathogenesis of RA: Immunization with Citrullinated T Cell Epitopes Is Sufficient to Induce Immunological and Clinical Manifestations of Arthritis in DR4-Transgenic Mice
  • Abstract Number: 0252
    Role of Clinical and Laboratory Parameters in Differentiating Infection from Disease Flare in Febrile Patients of Systemic Juvenile Idiopathic Arthritis
  • Abstract Number: 1821
    Role of Patient Organizations in Implementation of Recommended Non-pharmacological Treatment Modalities in Spondyloarthritis: Evidence for the Effectiveness of Self-management Strategies
  • Abstract Number: 0994
    Role of SLE Associated Cytokines in Generation of Mature Neutrophils
  • Abstract Number: 0527
    Role of Terminal Uridylyl Transferase 7 in TNF-α-Induced Inflammation in Rheumatoid Arthritis Synovial Fibroblasts In Vitro
  • Abstract Number: 1234
    Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy
  • Abstract Number: 1078
    Rural Veterans with Gout – “Rheum” for Improvement
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences